4//SEC Filing
Shakespeare William 4
Accession 0001745020-23-000060
CIK 0001745020other
Filed
Nov 6, 7:00 PM ET
Accepted
Nov 7, 4:03 PM ET
Size
6.9 KB
Accession
0001745020-23-000060
Insider Transaction Report
Form 4
Shakespeare William
See Remarks
Transactions
- Exercise/Conversion
Common Stock
2023-11-06$0.32/sh+251,084$80,347→ 639,408 total - Exercise/Conversion
Stock Option (right to buy)
2023-11-06−251,084→ 93,260 totalExercise: $0.32Exp: 2030-12-23→ Common Stock (251,084 underlying)
Footnotes (1)
- [F1]The options are immediately exercisable in full due to early exercise rights, subject to the issuer's right of repurchase. The options are subject to a service-based vesting requirement, which shall be satisfied over a four-year period with 1/48th of the options vesting monthly after November 18, 2020, subject to the Reporting Person's continuous service with the issuer.
Documents
Issuer
Theseus Pharmaceuticals, Inc.
CIK 0001745020
Entity typeother
Related Parties
1- filerCIK 0001879255
Filing Metadata
- Form type
- 4
- Filed
- Nov 6, 7:00 PM ET
- Accepted
- Nov 7, 4:03 PM ET
- Size
- 6.9 KB